KOSPIMachinery049800

Woojin Plaimm

₩1,827▲ 1.22%2026-11-18 close
Market Cap
₩36.5B
Turnover
₩69,063,004
Volume
40K
Shares out.
20M
PER
45.0×
PBR
0.3×
EPS
₩39
Dividend Yield
2.85%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩50 per share · Prices as of the 2026-11-18 close

01

Report overview

Profit Recovery Under Way After the Capex Cycle

Capex dropped sharply in 2025 and cash flow improved, and operating profit turned positive in Q2 and Q3 2026, but net profit attributable to owners over the last four quarters totals only KRW 789 million, so earnings strength is still thin.

  1. 1

    Revenue fell from KRW 254.6 billion in 2022 to KRW 211.6 billion in 2025, then reached KRW 60.2 billion in Q3 2026, up 33.9% year on year.

  2. 2

    Operating margin fell from 8.9% in 2022 to 0.7% in 2024 and edged up to 1.4% in 2025.

  3. 3

    According to CMIR, 2025 capex was KRW 6.7 billion, down 73% from KRW 25.1 billion a year earlier, while operating cash flow rose to KRW 10.7 billion.

  4. 4

    The Q3 2026 net loss attributable to owners of KRW 1.5 billion reflected foreign-currency translation losses tied to the weaker dollar, which the company said do not affect cash flow.

  5. 5

    Overseas sales rose to 33.9% of revenue in 2025, and the in-house WABOT take-out robot entered mass production in April 2026.

02

Business structure

Woojin Plaimm is a plastic injection molding machine developer, manufacturer and seller founded in 1985. It listed on KOSDAQ in 2001 and moved to the KOSPI market in 2006, and its core product remains the injection molding machine.

The company said it developed the take-out robot WABOT in-house and began mass production in April 2026 at a dedicated robot plant at its Boeun site in Chungbuk.

Sales of take-out robots and other purchased products, which the company had previously bought from outside suppliers and resold, reached KRW 18.1 billion in 2025 on a standalone basis, or 8.6% of standalone revenue (CMIR analysis).

CMIR argued that replacing these purchased products with in-house robots could improve profitability even at the same sales level. Overseas sales rose 24.8% to KRW 71.7 billion in 2025 and accounted for 33.9% of total revenue (CMIR analysis).

The company said it manages about 5,500 customers through 11 regional sales divisions across the country. The company said its Super-Foam and Clean-Foam injection technologies for automotive parts were co-developed with a global automaker and applied in mass production.

At its IN-HOUSE 2026 event in April 2026, it showed an operating structure linking injection molding machines, robots and process control as one system, with the automation platform built in cooperation with Austria's KEBA. CMIR rated the company as the number one injection molding machine maker in Korea.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩45B-₩600M−1.3%
2025Q4₩64.7B₩2.6B4.0%
2026Q1₩35.6B-₩4.1B−11.5%
2026Q2₩55.8B₩800M1.4%
2026Q3₩60.2B₩3.7B6.1%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩254.6B₩22.6B₩21.8B8.9%21.3%177.5%
2023₩212.1B₩9.1B₩6.1B4.3%5.7%199.2%
2024₩209.6B₩1.4B₩2.4B0.7%2.3%208.1%
2025₩211.6B₩2.9B₩2.3B1.4%2.1%186.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-16

04

Earnings analysis

Revenue went from KRW 254.6 billion in 2022 to KRW 212.1 billion in 2023 (down 16.7% year on year) and KRW 209.6 billion in 2024 (down 1.2%), then edged up to KRW 211.6 billion in 2025 (up 1.0%). Both revenue and operating profit were largest in 2022 and smallest in 2024 across the period.

Operating profit fell from KRW 22.6 billion in 2022 to KRW 9.06 billion in 2023 (down 59.9%) and KRW 1.39 billion in 2024 (down 84.7%), then recovered to KRW 2.93 billion in 2025 (up 110.8%). Operating margin was 8.9% in 2022, 4.3% in 2023, 0.7% in 2024 and 1.4% in 2025.

Net profit attributable to owners fell from KRW 21.8 billion in 2022 to KRW 6.05 billion in 2023, KRW 2.41 billion in 2024 and KRW 2.29 billion in 2025, a decline in each of three consecutive years from 2023 to 2025, while net profit including non-controlling interests was also KRW 2.29 billion in 2025.

CMIR analyzed that gross margin stayed in the 29% range from 2022's 29.9% through 2025 and was 28.0% in the first half of 2026. Operating margin fell even as gross margin held, which points to cost burdens below the gross profit line; CMIR also cited depreciation of KRW 11.3 billion in 2025.

The debt ratio rose from 177.5% in 2022 to 208.1% in 2024 before easing to 186.2% in 2025, when total liabilities were KRW 204.5 billion and total equity was KRW 109.8 billion.

Operating cash flow fell from KRW 26.4 billion in 2022 to KRW 5.72 billion in 2023 and KRW 5.54 billion in 2024, then rose to KRW 10.7 billion in 2025. CMIR said capex totaled KRW 53.6 billion over 2023 and 2024, and fell to KRW 6.7 billion in 2025, turning free cash flow positive at KRW 4.0 billion.

Quarterly operating profit moved from a loss of KRW 597 million in Q3 2025 to a profit of KRW 2.58 billion in Q4 2025, then a loss of KRW 4.09 billion in Q1 2026, followed by profits of KRW 803 million in Q2 and KRW 3.65 billion in Q3 2026.

Net profit attributable to owners was KRW 217 million in Q3 2025 and KRW 3.98 billion in Q4 2025, a loss of KRW 2.61 billion in Q1 2026, a profit of KRW 923 million in Q2 and a loss of KRW 1.5 billion in Q3 2026, so the last four quarters total KRW 789 million.

The company said the Q3 2026 net loss reflected non-cash foreign-currency translation losses tied to the exchange-rate decline.

05

Industry analysis

The company said demand for injection molding machines is shifting as production moves from packaging toward automotive parts and electrical and electronic products. It also said the importance of process automation is rising along the same trend.

Rising labor costs and wider automation demand were cited as the background for its shift toward integrated systems that combine molding machines with robots.

In automotive parts, rules on recycled plastic content are tightening, and the company presents its micro-foaming and recycled-resin molding technologies as a response. Company material also points to the EU tightening its recycled plastic use standards.

Production relocation is lifting demand in Southeast Asia, including Vietnam, and the company is expanding its overseas footholds. CMIR analyzed that the company's own concentrated investment cycle of 2023 and 2024 ended in 2025, reducing investment burden.

CMIR also argued that pricing competitiveness held up even as raw material prices rose. CMIR said this is the first case of a domestic injection molding machine maker developing and producing take-out robots in-house.

06

Outlook

In its 2026 corporate value-up plan, the company said it would keep capex at an appropriate level and expand overseas sales. According to a September 30, 2026 news report, the plan sets PBR targets of 0.5x for 2026, 0.75x for 2027 and at least 1.0x for 2028.

The same plan targets a total shareholder return ratio of at least 5.2% by 2028. On costs, the company plans to cut annual cost of sales by roughly KRW 3.5 billion to KRW 5.2 billion through in-house control units for WABOT, and to lower interest expense by repaying facility loans.

On shareholder returns, it plans to keep a minimum dividend standard for three years and to buy back and cancel at least 400,000 shares. In robotics, it plans to add a multi-joint robot lineup within 2026.

Overseas, it invited Vietnamese industry representatives to its headquarters and aims to convert technical cooperation into orders. The company also said it will hold quarterly earnings briefings four times a year.

The next checkpoints are whether the 0.5x PBR target is met at the end of 2026, and whether cost savings appear in the full-year 2026 results due in February 2027.

07

Valuation

PER
45.0×
PBR
0.3×
ROE
0.8%
EPS
₩39
BPS
₩5,268
Dividend per share
₩50

Valuation is easier to read when the share price is split into two axes: book equity and recent earnings. The price-to-book ratio fell from 0.95x in 2021 to 0.35x in 2025, and the current level sits in the lower part of that declining range.

The company attributed the lower price level to capex that grew equity faster than earnings. Market capitalization is below the book value of equity attributable to owners at year-end 2025, which was KRW 109.8 billion.

Earnings-based multiples look high because net profit attributable to owners over the last four quarters totals only KRW 789 million. The company plans to spend at least KRW 2.0 billion on dividends and share cancellation combined under its shareholder return plan.

Whether earnings recovery can catch up with the growth in equity is the central variable, and the company's target of at least 1.0x PBR by 2028 provides a reference point for that gap.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-16

08

Bull factors

Cash flow improves as the investment cycle ends

According to CMIR, 2025 capex was KRW 6.7 billion, down from KRW 25.1 billion in 2024. Operating cash flow reached KRW 10.7 billion in 2025, and free cash flow turned positive at KRW 4.0 billion. Net debt fell by KRW 5.8 billion, and the debt ratio eased from 208.1% in 2024 to 186.2% in 2025. The easing of borrowing pressure from the earlier large investment program is cited as a bullish factor.

Operating profit stays positive in Q2 and Q3 2026

Q2 2026 operating profit of KRW 803 million turned positive from a Q1 operating loss of KRW 4.09 billion. Q3 2026 revenue reached KRW 60.2 billion, up 33.9% year on year, and operating profit was KRW 3.65 billion. The company said higher domestic sales drove the improvement. CMIR argued that operating leverage could appear as revenue rises and fixed-cost pressure eases.

In-house robots and planned cost savings

CMIR argued that producing WABOT in-house, in place of purchased products, could raise profitability even at the same sales level. The company plans to cut annual cost of sales by roughly KRW 3.5 billion to KRW 5.2 billion through in-house control units. A multi-joint robot lineup is planned for addition within 2026. However, the robot segment's contribution to earnings has not yet been disclosed separately.

09

Bear factors

Earnings strength remains thin

Operating margin was 0.7% in 2024 and 1.4% in 2025, both low levels. Net profit attributable to owners over the last four quarters totals KRW 789 million, and Q3 2026 recorded a loss of KRW 1.5 billion. The company attributed that loss to foreign-currency translation losses from the exchange-rate decline. With earnings this small, non-operating items such as exchange rates can move net profit sharply.

Revenue contracted before quarterly swings widened

Revenue fell from KRW 254.6 billion in 2022 to KRW 211.6 billion in 2025. Net profit attributable to owners declined for three consecutive years from 2023 through 2025. Q3 2026 revenue showed signs of recovery, but Q1 2026 revenue fell 45.0% from the prior quarter. Large quarter-to-quarter swings mean the recovery trend is still at an early stage of confirmation.

Debt burden and interest cost remain

The debt ratio was 177.5% in 2022, peaked at 208.1% in 2024 and stood at 186.2% in 2025, still a high level. Total liabilities of KRW 204.5 billion at year-end 2025 exceeded total equity of KRW 109.8 billion.

The company said it would lower interest expense by repaying facility loans, but results from that plan have not yet appeared. If borrowing pressure does not ease, gains in earnings could be absorbed by interest costs.

10

Risk factors

FX and translation gains and losses

With overseas sales at 33.9% of revenue in 2025, exchange-rate moves feed into earnings. The Q3 2026 loss attributable to owners reflected translation losses from the exchange-rate decline. The company said these losses do not involve cash outflows. If exchange rates keep moving unfavorably, quarterly net profit could continue to swing.

Raw material and cost pressure

CMIR argued that pricing competitiveness held despite higher raw material costs. However, if cost increases cannot be passed on to customers, operating margin could fall again. Gross margin was 28.0% in the first half of 2026, below 29.9% in 2022. The pace of the planned cost reductions will be a key variable for this figure.

Renewed capex and funding needs

The company said that after investing KRW 53.6 billion in capex over 2023 and 2024, equity grew faster than earnings. The robot plant and the expansion of the robot lineup could create additional funding needs. The company said it would keep capex at an appropriate level without disclosing a specific amount. A renewed rise in investment could offset the cash flow gains.

11

What to watch next

  1. As of December 31, 2026

    The value-up plan sets a 2026 PBR target of 0.5x. Whether the target is met, along with progress on share buybacks and cancellation, can be checked at year-end.

  2. By end-December 2026

    This is the checkpoint for whether the planned multi-joint robot lineup is added. As the robot range expands, it will also show whether robot segment sales are disclosed separately.

  3. February 2027

    This is when the Q4 and full-year 2026 preliminary results are expected. The 2025 full-year results were disclosed on February 27, 2026, and the 2025 operating margin of 1.4% provides a benchmark for judging whether cost savings appear.

  4. By March 31, 2027

    The 2026 annual report is due. The full-year and quarterly 2026 figures will be fixed in the periodic report, and the operating margin in that report is the next checkpoint.

12

Overall view

Woojin Plaimm's revenue and operating profit declined after 2022, operating profit rebounded in 2025, and it stayed positive in Q2 and Q3 2026. Capex fell to KRW 6.7 billion in 2025, improving operating cash flow and free cash flow.

On the other side, net profit attributable to owners over the last four quarters totals only KRW 789 million, and Q3 2026 posted a net loss due to translation losses.

The in-house WABOT robot, cost-reduction and shareholder return plans are presented as levers to strengthen earnings, but their contribution to results has not yet been separately confirmed.

The debt ratio of 186.2% is high and the 2025 operating margin of 1.4% is low, so the pace of earnings recovery is the central issue. Valuation can be read as a low share price relative to book equity alongside a small earnings base.

Because bullish and bearish factors coexist, the next checkpoints are the year-end 2026 PBR target review, the full-year preliminary results expected in February 2027, and the 2026 annual report due by March 2027.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. digitaltoday.co.kr
  2. newspim.com
  3. vegannews.co.kr
  4. newspim.com
  5. thedailypost.kr
  6. comp.wisereport.co.kr
  7. news.nate.com
  8. digitaltoday.co.kr
  9. m.news.nate.com
  10. newspim.com
  11. digitaltoday.co.kr
  12. newspim.com
  13. newspim.com
  14. kidd.co.kr
  15. m.news.nate.com
  16. hankyung.com

Report written 2026-11-16 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis